Morningstar

Global News Select

Legend Biotech Down Over 10%, on Pace for Largest Percent Decrease Since July 2022 — Data Talk

Provided by Dow Jones

Sep 6, 2024 5:10pm

Legend Biotech Corp. Sponsored ADR ( LEGN ) is currently at $48.35, down $5.70 or 10.55%

--Would be lowest close since July 10, 2024, when it closed at $47.32

--On pace for largest percent decrease since July 26, 2022, when it fell 13.88%

--Currently down three of the past four days

--Currently down two consecutive days; down 15.75% over this period

--Worst two day stretch since the two days ending March 14, 2022, when it fell 16.16%

--Down 19.64% year-to-date

--Down 36.8% from its all-time closing high of $76.50 on July 28, 2023

--Down 28.52% from 52 weeks ago (Sept. 8, 2023), when it closed at $67.64

--Down 31.04% from its 52-week closing high of $70.11 on Sept. 11, 2023

--Up 22.41% from its 52-week closing low of $39.50 on May 23, 2024

--Traded as low as $47.75; lowest intraday level since July 11, 2024, when it hit $47.12

--Down 11.66% at today's intraday low; largest intraday percent decrease since July 26, 2022, when it fell as much as 14.12%

All data as of 12:52:46 PM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 06, 2024 13:10 ET (17:10 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2024 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.